Psychopathy, Substance Use
Conditions
Keywords
substance use, psychopathy, motivational enhancement, criminal recidivism
Brief summary
Substance use among criminal offenders constitutes a major public health problem and is tied to negative consequences for offenders, their families, and their communities. One of the direst of these consequences is repeated incarceration; thus, interventions that reduce criminal recidivism are needed. Forensic populations are often viewed with considerable therapeutic pessimism. However, offenders exhibit heterogeneity in personality traits, and the assessment of individual differences among offenders may provide valuable information that guides the use of psychotherapeutic interventions. Among offenders, psychopathy has emerged as an important personality construct for the understanding of violence and criminal recidivism. Moreover, core traits of psychopathy such as lack of empathy, deceitfulness, and lack of remorse may have negative implications for the efficacy of psychosocial interventions. A foundational premise of the present work is that understanding the moderating role of psychopathic traits on substance use treatment outcomes among offenders is essential to determining what works, and for whom. The current proposal is a Phase II randomized clinical trial that aims to examine the impact of psychopathic traits on the efficacy of a brief substance use intervention for offenders in a jail diversion program. Hypotheses that will be examined include: 1) that a Motivational Interviewing (MI) - based treatment will reduce substance use and related consequences relative to a Standard Care only condition, 2) that the reduction in substance use in the intervention group will mediate a reduction in later criminal recidivism relative to the Standard Care condition, and 3) that core psychopathic traits will moderate the efficacy of the intervention such that individuals with lower levels of these traits will derive greater benefits with regard to decreased substance use, decreased drug use consequences, and decreased criminal recidivism at a one-year follow-up.
Detailed description
Substance use among criminal offenders constitutes a major public health problem and is tied to negative consequences for offenders, their families, and their communities. One of the direst of these consequences is repeated incarceration; thus, interventions that reduce criminal recidivism are needed. Forensic populations are often viewed with considerable therapeutic pessimism. However, offenders exhibit heterogeneity in personality traits, and the assessment of individual differences among offenders may provide valuable information that guides the use of psychotherapeutic interventions. Among offenders, psychopathy has emerged as an important personality construct for the understanding of violence and criminal recidivism. Moreover, core traits of psychopathy such as lack of empathy, deceitfulness, and lack of remorse may have negative implications for the efficacy of psychosocial interventions. A foundational premise of the present work is that understanding the moderating role of psychopathic traits on substance use treatment outcomes among offenders is essential to determining what works, and for whom. The current proposal is a Phase II randomized clinical trial that aims to examine the impact of psychopathic traits on the efficacy of a brief substance use intervention for offenders in a jail diversion program. Hypotheses that will be examined include: 1) that a Motivational Interviewing (MI) - based treatment will reduce substance use and related consequences relative to a Standard Care only condition, 2) that the reduction in substance use in the intervention group will mediate a reduction in later criminal recidivism relative to the Standard Care condition, and 3) that core psychopathic traits will moderate the efficacy of the intervention such that individuals with lower levels of these traits will derive greater benefits with regard to decreased substance use, decreased drug use consequences, and decreased criminal recidivism at a one-year follow-up. This work has the potential to provide important data regarding which individuals can benefit from a brief intervention for substance use. Such data will inform the effective and efficient allocation of treatment resources for substance using offenders.
Interventions
Four 45-minute MET sessions
Sponsors
Study design
Eligibility
Inclusion criteria
* In local pretrial services program; English speaking
Exclusion criteria
* Psychosis, inability to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percent Days Abstinent Per Month From Drug Use | three to six months post baseline | Using timeline followback data, frequency of substance use was assessed for months three through six and presented as average percent days abstinent per month. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Shortened Inventory of Problems With Alcohol and Drugs (SIP-AD) | six months | A measure of consequences of drug and alcohol use across several domains (e.g., social, work, health), SIP-AD scores range from 0-45, with higher scores indicating higher levels of substance use consequences. |
| New Criminal Charge | one year | New criminal charge vs. no new criminal charge at follow-up as indicated by county database. |
Countries
United States
Participant flow
Recruitment details
Recruitment took place at a jail diversion program in Upstate NY between 2009 and 2014.
Pre-assignment details
Inclusion criteria were harmful substance use in the past 6 months and enrollment in a jail diversion program subsequent to being charged with a crime.
Participants by arm
| Arm | Count |
|---|---|
| Brief Motivational Intervention Plus Standard Care (BMI+SC) Brief Motivational Intervention plus Standard Care; Individuals received up to 4 intervention sessions plus assessment and the usual range of services provided by Monroe County Pretrial | 53 |
| Standard Care (SC) Standard Care: Individuals received assessment only, plus the usual range of services provided by Monroe County Pretrial | 52 |
| Total | 105 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | In controlled environment | 3 | 2 |
| Overall Study | Lost to Follow-up | 11 | 11 |
Baseline characteristics
| Characteristic | Brief Motivational Intervention Plus Standard Care (BMI+SC) | Standard Care (SC) | Total |
|---|---|---|---|
| Age, Continuous | 33.1 years STANDARD_DEVIATION 10 | 33.8 years STANDARD_DEVIATION 11.8 | 33.4 years STANDARD_DEVIATION 10.9 |
| Psychopathy Checklist-Revised - Factor One (F1) | 8.1 units on a scale STANDARD_DEVIATION 4.3 | 9.0 units on a scale STANDARD_DEVIATION 4.4 | 8.6 units on a scale STANDARD_DEVIATION 4.3 |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 21 Participants | 24 Participants | 45 Participants |
| Race (NIH/OMB) More than one race | 8 Participants | 2 Participants | 10 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 24 Participants | 26 Participants | 50 Participants |
| Region of Enrollment United States | 53 participants | 52 participants | 105 participants |
| Sex: Female, Male Female | 23 Participants | 14 Participants | 37 Participants |
| Sex: Female, Male Male | 30 Participants | 38 Participants | 68 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 53 | 0 / 52 |
| serious Total, serious adverse events | 0 / 53 | 0 / 52 |
Outcome results
Percent Days Abstinent Per Month From Drug Use
Using timeline followback data, frequency of substance use was assessed for months three through six and presented as average percent days abstinent per month.
Time frame: three to six months post baseline
Population: 105 adults (68 men and 37 women) were recruited in an urban pretrial jail diversion program. 78 (74.3%) were retained through six months. Of these, 73 were out of controlled environments (e.g., jail, inpatient treatment) for long enough to have their substance use data analyzed.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| BMI+SC | Percent Days Abstinent Per Month From Drug Use | 46.92 percentage of days abstinent | Standard Deviation 37.46 |
| Standard Care | Percent Days Abstinent Per Month From Drug Use | 55.16 percentage of days abstinent | Standard Deviation 42.09 |
New Criminal Charge
New criminal charge vs. no new criminal charge at follow-up as indicated by county database.
Time frame: one year
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| BMI+SC | New Criminal Charge | 23 participants |
| Standard Care | New Criminal Charge | 22 participants |
Shortened Inventory of Problems With Alcohol and Drugs (SIP-AD)
A measure of consequences of drug and alcohol use across several domains (e.g., social, work, health), SIP-AD scores range from 0-45, with higher scores indicating higher levels of substance use consequences.
Time frame: six months
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| BMI+SC | Shortened Inventory of Problems With Alcohol and Drugs (SIP-AD) | 10.69 units on a scale | Standard Deviation 13.21 |
| Standard Care | Shortened Inventory of Problems With Alcohol and Drugs (SIP-AD) | 15.24 units on a scale | Standard Deviation 14.28 |